<DOC>
	<DOCNO>NCT01240759</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy S-707106 co-administered metformin subject type 2 diabetes mellitus .</brief_summary>
	<brief_title>Safety Efficacy S-707106 Subjects With Type 2 Diabetes Mellitus Inadequate Glycemic Control With Metformin Therapy</brief_title>
	<detailed_description>Based unmet clinical need safe effective type 2 diabetes mellitus therapy , together nonclinical efficacy safety profile S-707106 , Shionogi USA , Inc. initiate study assess efficacy , clinical pharmacology safety profile S-707106 preparation full clinical development novel treatment type 2 diabetes mellitus . It anticipate S-707106 provide clinician patient new therapeutic option treat type 2 diabetes mellitus potential advantage exist therapy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Main Subjects type 2 diabetes mellitus receive stable dose metformin past 3 month ( medication glycemic control ) clinically stable determined medical history Body mass index ( BMI ) ≥25.0 &lt; 45.0 ( kg/m2 ) use http : //www.bmicalculator.org/ BMI calculator No clinically significant abnormal laboratory test determine investigator except Hemoglobin A1c level ≥7.5 % ≤11.0 % C peptide level &gt; 1.0 ng/mL Main Type 1 diabetes mellitus gestational diabetes mellitus within last 6 month Use medication glycemic control metformin past 3 month thiazolidinediones within past year Congestive heart failure define New York Heart Association class III IV Fasting glucose &gt; 270 mg/dL Creatinine clearance &lt; 60 mL/minute History myocardial infarction within past 3 month , history clinically significant cardiac arrhythmia , clinically significant hypotension hypertension , clinically significant abnormal electrocardiogram determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Metformin</keyword>
</DOC>